Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 1
1951 1
1952 1
1954 1
1956 2
1960 1
1963 1
1966 4
1967 4
1968 7
1969 9
1970 1
1971 2
1972 6
1974 7
1975 5
1976 3
1977 11
1978 1
1979 7
1980 8
1981 12
1982 18
1983 6
1984 8
1985 15
1986 17
1987 16
1988 9
1989 13
1990 7
1991 12
1992 6
1993 11
1994 21
1995 29
1996 24
1997 19
1998 14
1999 11
2000 8
2001 13
2002 11
2003 14
2004 8
2005 15
2006 15
2007 18
2008 23
2009 39
2010 33
2011 41
2012 53
2013 55
2014 44
2015 48
2016 47
2017 43
2018 52
2019 48
2020 56
2021 70
2022 62
2023 71
2024 64
2025 49

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,234 results

Results by year

Filters applied: . Clear all
Page 1
A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growth.
Morelli E, Fulciniti M, Samur MK, Ribeiro CF, Wert-Lamas L, Henninger JE, Gullà A, Aktas-Samur A, Todoerti K, Talluri S, Park WD, Federico C, Scionti F, Amodio N, Bianchi G, Johnstone M, Liu N, Gramegna D, Maisano D, Russo NA, Lin C, Tai YT, Neri A, Chauhan D, Hideshima T, Shammas MA, Tassone P, Gryaznov S, Young RA, Anderson KC, Novina CD, Loda M, Munshi NC. Morelli E, et al. Among authors: neri a. Blood. 2023 Jan 26;141(4):391-405. doi: 10.1182/blood.2022016892. Blood. 2023. PMID: 36126301 Free PMC article.
Talquetamab in Multiple Myeloma: Efficacy, Safety, and Future Directions.
Labanca C, Martino EA, Vigna E, Bruzzese A, Mendicino F, Lucia E, Olivito V, Puccio N, Neri A, Morabito F, Gentile M. Labanca C, et al. Among authors: neri a. Eur J Haematol. 2025 Mar;114(3):386-399. doi: 10.1111/ejh.14353. Epub 2024 Nov 27. Eur J Haematol. 2025. PMID: 39604778 Free PMC article. Review.
Momelotinib in myelofibrosis.
Bruzzese A, Martino EA, Labanca C, Mendicino F, Lucia E, Olivito V, Zimbo A, Fragliasso V, Neri A, Morabito F, Vigna E, Gentile M. Bruzzese A, et al. Among authors: neri a. Expert Opin Pharmacother. 2024 Apr;25(5):521-528. doi: 10.1080/14656566.2024.2343780. Epub 2024 Apr 18. Expert Opin Pharmacother. 2024. PMID: 38623844 Review.
Potential of BGB-11417, a BCL2 inhibitor, in hematological malignancies.
Bruzzese A, Martino EA, Labanca C, Mendicino F, Lucia E, Olivito V, Neri A, Morabito F, Vigna E, Gentile M. Bruzzese A, et al. Among authors: neri a. Expert Opin Investig Drugs. 2024 Feb;33(2):73-77. doi: 10.1080/13543784.2024.2309873. Epub 2024 Jan 26. Expert Opin Investig Drugs. 2024. PMID: 38264792 No abstract available.
Isatuximab in multiple myeloma.
Martino EA, Bruzzese A, Iaccino E, Mendicino F, Mimmi S, Lucia E, Olivito V, Neri A, Morabito F, Vigna E, Gentile M. Martino EA, et al. Among authors: neri a. Expert Opin Biol Ther. 2023 Apr;23(4):315-318. doi: 10.1080/14712598.2023.2193289. Epub 2023 Mar 24. Expert Opin Biol Ther. 2023. PMID: 36943846 No abstract available.
Elotuzumab in multiple myeloma.
Bruzzese A, Martino EA, Vigna E, Iaccino E, Mendicino F, Lucia E, Olivito V, Filippelli G, Neri A, Morabito F, Gentile M. Bruzzese A, et al. Among authors: neri a. Expert Opin Biol Ther. 2023 Jan;23(1):7-10. doi: 10.1080/14712598.2022.2145882. Epub 2022 Nov 14. Expert Opin Biol Ther. 2023. PMID: 36373842 No abstract available.
Belantamab mafodotin in multiple myeloma.
Martino EA, Bruzzese A, Iaccino E, Labanca C, Mendicino F, Mimmi S, Lucia E, Olivito V, Neri A, Morabito F, Vigna E, Gentile M. Martino EA, et al. Among authors: neri a. Expert Opin Biol Ther. 2023 Jul-Dec;23(11):1043-1047. doi: 10.1080/14712598.2023.2218543. Epub 2023 May 27. Expert Opin Biol Ther. 2023. PMID: 37227998 No abstract available.
Venetoclax in acute myeloid leukemia.
Bruzzese A, Martino EA, Mendicino F, Lucia E, Olivito V, Neri A, Morabito F, Vigna E, Gentile M. Bruzzese A, et al. Among authors: neri a. Expert Opin Investig Drugs. 2023 Apr;32(4):271-276. doi: 10.1080/13543784.2023.2193679. Epub 2023 Mar 23. Expert Opin Investig Drugs. 2023. PMID: 36933006 No abstract available.
Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axis.
Sacco A, Desantis V, Celay J, Giustini V, Rigali F, Savino FD, Cea M, Soncini D, Cagnetta A, Solimando AG, D'Aliberti D, Spinelli S, Ramazzotti D, Almici C, Todoerti K, Neri A, Anastasia A, Tucci A, Motta M, Chiarini M, Kawano Y, Martinez-Climent JA, Piazza R, Roccaro AM. Sacco A, et al. Among authors: neri a. Blood. 2023 May 25;141(21):2615-2628. doi: 10.1182/blood.2022019240. Blood. 2023. PMID: 36735903 Free article.
1,234 results